Hydroxyphenyl derivatives and biological applications thereof
AssigneeFab Pharma S.A.S.
InventorsAlexis Denis, Vincent Gerusz, Yannick Bonvin
Life of this patent
Estimating the term…
Abstract
The invention relates to hydroxyphenyl derivatives of formula (I); and uses thereof as anti-bacterial and/or anti-parasitic agents.
Claims5
A method of treatment of microbial infection which comprises administering to a patient in need thereof an effective amount of a hydroxyphenyl derivative of formula (I), wherein the microbial infection is an infection by bacteria carrying the FabI enzyme;
- R1 is phenyl
- R1 being optionally substituted by 1 to 3 R identical or different, R being selected from the group comprising H, fluoro, C1-C8 alkyl, C1-C4fluoro-alkyl, C2-C8 alkenyl, C2-C8 alkynyl, COORa, CORa, CONRaRb, OCORa, CN, ORa, NRaRb, CRa═NORb, NRaCOORb, OCONRaRb, NRaCONRbRc, SRa, SO2Ra, SO2NRaRb, and NRaC(S)NRbRc, all being possibly substituted by R′,
- R2 is C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C4fluoro-alkyl, C2-C4fluoro-alkenyl, ORa, SRa, all being possibly substituted by 1 to 3 identical or different R′,
- Ra, Rb and Rc, identical or different, are selected from the group consisting of H, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl,
- R′ is selected from the group comprising C1-C8 alkyl, CH2CO2R″, CO2R″, COR″, CONR″R′″, OCOR″, OR″, NR″R′″, NR″COR′″, NR″COOR′″, OCONR″R′″, NR″CONR″R′″, NR″SO2R′″, SO2R″, NR″SO2R′″, halogen and CN, R″ and R′″, identical or different, are H or C1-C8 alkyl,
- Y represents H,
- Z1 and Z3, identical or different, are halogen or H,
- Z2 is fluoro,
- or a pharmaceutically acceptable organic or mineral salt, as well as the racemic derivatives and each unique not racemic derivatives, in case the derivatives of formula (I) have one or more chiral centers, both the cis (Z) and trans (E) isomers, in cases the derivatives of formula (I) have unsaturated carbon=carbon double bonds, and any N-oxide form of the derivatives.
A method of treatment of microbial infection which comprises administering to a patient in need thereof an effective amount of a hydroxyphenyl derivative of formula (I), wherein the microbial infection is an infection by bacteria carrying the FabI enzyme;
- R1 is phenyl substituted by 1 to 3 R identical or different, R being selected from the group comprising H, fluoro, C1-C8 alkyl, C1-C4 fluoro-alkyl, C2-C8 alkenyl, C2-C8 alkynyl, COORa, CORa, CONRaRb, OCORa, CN, ORa, NRaRb, CRa═NORb, NRaCOORb, OCONRaRb, NRaCONRbRc, SRa, SO2Ra, SO2NRaRb and NRaC(S)NRbRc,
- R2 is C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C4fluoro-alkyl, C2-C4fluoro-alkenyl, ORa or SRa,
- Ra, Rb and Rc, identical or different, are selected from the group consisting of H, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl;
- Y represents H,
- Z1 and Z3 are both H,
- Z2 is fluoro,
- or a pharmaceutically acceptable organic or mineral salt, as well as the racemic derivatives and each unique not racemic derivatives, in case the derivatives of formula (I) have one or more chiral centers, both the cis (Z) and trans (E) isomers, in cases the derivatives of formula (I) have unsaturated carbon=carbon double bonds, and any N-oxide form of the derivatives.
Dependencies are inferred from the claim text.